TTrialPathMatch Me to Trials
← Back to trials
RecruitingSolid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm

Intravital Microscopy in Human Solid Tumors

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.

Sponsor: Mayo Clinic

You may qualify if…

  • Age ≥ 18 years of age
  • Eastern Cooperative Oncology Group (ECOG)Performance Status of ≤ 2
  • Measurable tumor by direct visualization requiring surgical resection in the operating room (OR)
  • Tumor types of origin include gastric, pancreatic, hepatobiliary, colorectal, sarcoma, brain, or breast cancer that may involve the axillary lymph nodes cancers. Tumors may be primary or metastatic
  • Subject must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent
  • Subject must have a skin prick test pre-operatively (at the time of the preoperative visit and after signed informed consent for entry into this clinical trial is given) to determine any sensitivity to fluorescein

You may not qualify if…

  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations
  • Renal dysfunction as defined as a glomerular filtration rate (GFR) \< 45
  • Liver dysfunction as defined by Child-Pugh score \> 5, or liver function test (LFT)'s 1.5 x above normal range
  • Any known allergy or prior reaction to fluorescein or a positive skin prick test to fluorescein
  • Pregnant or nursing female subjects, determined preoperatively with a urine pregnancy test
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the investigators' opinion deems the patient unsuitable (e.g., abnormal electrocardiography \[EKG\], including T wave inversion, elevated T waves, prolonged QRS interval, or conduction blocks) or that requires further work-up (including cardiac echo or stress test)
  • Any condition that excludes surgical resection as the standard of care for the patient

Where it's recruiting

Florida

Jacksonville

Source: ClinicalTrials.gov · NCT03823144 · last updated 2026-06-02

Intravital Microscopy in Human Solid Tumors · TrialPath